Canada Pension Plan Investment Board’s Immunovant IMVT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$867K	Sell	22,500 -700	-3%	-$21.3K	﹤0.01%	1058
2026 Q1	$576K	Buy	23,200 +18,000	+346%	+$466K	﹤0.01%	1191
2025 Q4	$132K	Sell	5,200 -409,600	-99%	-$9.13M	﹤0.01%	1761
2025 Q3	$6.69M	Hold	414,800	–	–	﹤0.01%	713
2025 Q2	$6.64M	Buy	414,800 +232,300	+127%	+$3.51M	0.01%	665
2025 Q1	$3.12M	Buy	182,500 +87,300	+92%	+$1.83M	﹤0.01%	755
2024 Q4	$2.36M	Buy	95,200 +94,000	+7,833%	+$2.67M	﹤0.01%	851
2024 Q3	$34.2K	Sell	1,200 -198,600	-99%	-$5.86M	﹤0.01%	1263
2024 Q2	$5.27M	Buy	+199,800	New	+$5.68M	0.01%	711

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Canada Pension Plan Investment Board's IMVT Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Immunovant (IMVT) stake by 3% in Q2 2026, selling an estimated $21.3K and leaving 22,500 shares worth $867K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

Canada Pension Plan Investment Board first reported a position in IMVT in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.69M in Q3 2025. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Canada Pension Plan Investment Board held 22,500 shares of Immunovant worth $867K as of Q2 2026.
Canada Pension Plan Investment Board sold 700 Immunovant shares in Q2 2026, an estimated $21.3K.
Immunovant made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1058 holding.
Canada Pension Plan Investment Board first reported a position in Immunovant in Q2 2024 and has held it in 9 quarters since.
Canada Pension Plan Investment Board's Immunovant position peaked at $6.69M in Q3 2025.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.